1. Home
  2. Inspections, Compliance, Enforcement, and Criminal Investigations
  3. Compliance Actions and Activities
  4. Warning Letters
  1. Compliance Actions and Activities

Warning Letters

Learn about the types of warning letters on FDA's website.

  • Matters described in FDA warning letters may have been subject to subsequent interaction between FDA and the letter recipient that may have changed the regulatory status of issues discussed in the letter.
  • To obtain additional available information, contact FDA. Requests to FDA for agency records should be sent to: Food and Drug Administration Division of Freedom of Information (HFI-35), 5630 Fishers Lane, Rockville, MD 20857. Instructions for how to submit an FOI request can be found at How to Make a FOIA Request.
  • Frequently requested records may be accessed on the Reading Room page.

 


Posted Date Letter Issue Date Company Name Issuing Office Subject Response Letter Closeout Letter Excerpt
MantroForce Center for Drug Evaluation and Research (CDER) Unapproved New Drugs/Misbranded

Great India Overseas Pvt. Ltd. dba Silkrute Center for Drug Evaluation and Research (CDER) Unapproved New Drugs
Leading Edge Health Inc. Center for Drug Evaluation and Research (CDER) Unapproved New Drugs/Misbranded
Indiangoods.shop Center for Drug Evaluation and Research (CDER) Unapproved New Drugs/Misbranded
Wild Arabic Herbs Center for Drug Evaluation and Research (CDER) Unapproved New Drugs/Misbranded
Texinkart Inc. Center for Drug Evaluation and Research (CDER) Unapproved New Drugs/Misbranded
Hadassah Healing Oils Ltd Center for Drug Evaluation and Research (CDER) Unapproved New Drugs
Huons Co., Ltd. Center for Drug Evaluation and Research (CDER) CGMP/Finished Pharmaceuticals/Adulterated
Imu-Tek Animal Health, Incorporated Human Foods Program Dietary Supplement/New Drug/Misbranded
Vivot LLC Office of Inspections and Investigations Foreign Supplier Verification Program (FSVP)

SUBSCRIBE

Get regular FDA email updates delivered on this topic to your inbox.
Back to Top